Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
复制标题
DOI：
10.1016/j.jaci.2010.06.047
复制
发表时间：
2010-09-01
影响因子：
14.2
通讯作者：
Schuenemann, Holger J.
中科院分区：
文献类型：
--
作者：
Brozek, Jan L.;Bousquet, Jean;Schuenemann, Holger J.
背景：过敏性鼻炎是一个全球性的健康问题，影响10%至20%的人口。变应性鼻炎及其对哮喘的影响（ARIA）指南已被广泛用于治疗全球约5亿受影响的患者。目的：根据目前最佳证据，系统地制定明确，明确和透明的临床建议，用于治疗变应性鼻炎。研究方法：作者与全球过敏和哮喘欧洲网络合作，按照建议评估、发展和评估工作组提出的方法更新了ARIA临床建议。结果：这篇文章提出了关于预防过敏性疾病，使用口服和局部药物，过敏原特异性免疫治疗，以及过敏性鼻炎患者以及过敏性鼻炎和哮喘患者的补充治疗。该指南小组制定的证据配置文件，为每个建议，并考虑健康的好处和危害，负担，患者的喜好，和资源的使用，在适当的时候，制定建议，为患者，临床医生和其他卫生保健professionals.Conclusion：这些是最近的，目前最系统和透明的发展建议有关成人和儿童过敏性鼻炎的治疗。鼓励患者、临床医生和政策制定者在日常实践中使用这些建议，并支持他们的决定。（J Allergy Clin Immunol 2010;126：466-76.）
Background: Allergic rhinitis represents a global health problem affecting 10% to 20% of the population. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines have been widely used to treat the approximately 500 million affected patients globally.Objective: To develop explicit, unambiguous, and transparent clinical recommendations systematically for treatment of allergic rhinitis on the basis of current best evidence. Methods: The authors updated ARIA clinical recommendations in collaboration with Global Allergy and Asthma European Network following the approach suggested by the Grading of Recommendations Assessment, Development and Evaluation working group.Results: This article presents recommendations about the prevention of allergic diseases, the use of oral and topical medications, allergen specific immunotherapy, and complementary treatments in patients with allergic rhinitis as well as patients with both allergic rhinitis and asthma. The guideline panel developed evidence profiles for each recommendation and considered health benefits and harms, burden, patient preferences, and resource use, when appropriate, to formulate recommendations for patients, clinicians, and other health care professionals.Conclusion: These are the most recent and currently the most systematically and transparently developed recommendations about the treatment of allergic rhinitis in adults and children. Patients, clinicians, and policy makers are encouraged to use these recommendations in their daily practice and to support their decisions. (J Allergy Clin Immunol 2010;126:466-76.)